Stress Factor

Chronic Stress Diagnostic Kit

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Pre-Funding Be'er Sheva Founded 2018
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
6
HQ
Be'er Sheva
Sector
Health Tech & Life Sciences

About

Stress Factor has developed a diagnostics kit designed to measure a specific immunodeficiency caused by chronic stress. The company uses a blood test to quantify and score an individuals ability to fight inflammation (which is impaired by chronic stress exposure), a key factor in the pathophysiology of many chronic diseases. This score can be an important tool for physicians to use in the diagnosis, treatment, and prediction of many chronic or inflammatory diseases.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Stress Factor's primary product?
Stress Factor has developed a diagnostics kit that uses a blood test to measure an immunodeficiency caused by chronic stress. This kit quantifies an individual's ability to fight inflammation.
When was Stress Factor founded?
Stress Factor was founded in February 2018.
What is the current operational status of Stress Factor?
Stress Factor is currently inactive, having ceased operations in December 2020.
Where is Stress Factor headquartered?
Stress Factor is headquartered in Be'er Sheva, Israel.
What is Stress Factor's primary sector?
Stress Factor's primary sector is Health Tech & Life Sciences.
How many employees did Stress Factor have?
Stress Factor had 6 employees.
What is Stress Factor's current funding stage?
Stress Factor is in the Pre-Funding stage.
Who are the founders of Stress Factor?
The founders of Stress Factor are Oren Markus and Idan Harpaz.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

inflammatory-diseasesbiomarkersdiagnosticsmedical-technologiesblood-test